| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bone sialoprotein binding | 9.53e-07 | 2 | 20 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 9.51e-06 | 5 | 20 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.14e-05 | 211 | 20 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 6.25e-05 | 12 | 20 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | phospholipase inhibitor activity | 7.39e-05 | 13 | 20 | 2 | GO:0004859 | |
| GeneOntologyMolecularFunction | S100 protein binding | 9.93e-05 | 15 | 20 | 2 | GO:0044548 | |
| GeneOntologyMolecularFunction | lipase inhibitor activity | 1.44e-04 | 18 | 20 | 2 | GO:0055102 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor binding | 1.44e-04 | 18 | 20 | 2 | GO:0005159 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.71e-04 | 288 | 20 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.55e-04 | 28 | 20 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | protein sequestering activity | 5.25e-04 | 34 | 20 | 2 | GO:0140311 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.43e-04 | 172 | 20 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 8.40e-04 | 43 | 20 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | molecular sequestering activity | 1.58e-03 | 59 | 20 | 2 | GO:0140313 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 1.63e-03 | 60 | 20 | 2 | GO:0005544 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 2.15e-03 | 69 | 20 | 2 | GO:0045309 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 2.40e-03 | 73 | 20 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 2.40e-03 | 73 | 20 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.83e-03 | 321 | 20 | 3 | GO:0031267 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 4.02e-03 | 95 | 20 | 2 | GO:0005546 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 4.28e-03 | 98 | 20 | 2 | GO:0048306 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.62e-03 | 102 | 20 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 4.89e-03 | 105 | 20 | 2 | GO:0004867 | |
| GeneOntologyMolecularFunction | GTPase binding | 5.28e-03 | 360 | 20 | 3 | GO:0051020 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 6.04e-03 | 117 | 20 | 2 | GO:0051219 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 6.44e-03 | 121 | 20 | 2 | GO:1902936 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 6.55e-03 | 122 | 20 | 2 | GO:0072341 | |
| GeneOntologyMolecularFunction | antiporter activity | 8.30e-03 | 138 | 20 | 2 | GO:0015297 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 8.89e-03 | 435 | 20 | 3 | GO:0004857 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.38e-02 | 180 | 20 | 2 | GO:0004866 | |
| GeneOntologyMolecularFunction | protease binding | 1.39e-02 | 181 | 20 | 2 | GO:0002020 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.48e-02 | 187 | 20 | 2 | GO:0030414 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.67e-02 | 199 | 20 | 2 | GO:1901981 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.70e-02 | 201 | 20 | 2 | GO:0061135 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 9.87e-07 | 2 | 21 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 2.96e-06 | 3 | 21 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 2.96e-06 | 3 | 21 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 5.92e-06 | 4 | 21 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 5.92e-06 | 4 | 21 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 5.92e-06 | 4 | 21 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 5.92e-06 | 4 | 21 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane repair | 9.85e-06 | 5 | 21 | 2 | GO:1905686 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor binding | 9.85e-06 | 5 | 21 | 2 | GO:1905595 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular lipid transport | 9.85e-06 | 5 | 21 | 2 | GO:0032379 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein receptor activity | 1.48e-05 | 6 | 21 | 2 | GO:1905599 | |
| GeneOntologyBiologicalProcess | negative regulation of TORC1 signaling | 1.95e-05 | 52 | 21 | 3 | GO:1904262 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 2.07e-05 | 7 | 21 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 2.07e-05 | 7 | 21 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 2.07e-05 | 7 | 21 | 2 | GO:0032799 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis involved in cholesterol transport | 2.75e-05 | 8 | 21 | 2 | GO:1905600 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor binding | 2.75e-05 | 8 | 21 | 2 | GO:1900122 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane repair | 2.75e-05 | 8 | 21 | 2 | GO:1905684 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 5.40e-05 | 11 | 21 | 2 | GO:0090118 | |
| GeneOntologyBiologicalProcess | negative regulation of TOR signaling | 5.63e-05 | 74 | 21 | 3 | GO:0032007 | |
| GeneOntologyBiologicalProcess | positive regulation of lipoprotein particle clearance | 6.48e-05 | 12 | 21 | 2 | GO:0010986 | |
| GeneOntologyBiologicalProcess | regulation of intracellular sterol transport | 6.48e-05 | 12 | 21 | 2 | GO:0032380 | |
| GeneOntologyBiologicalProcess | regulation of intracellular cholesterol transport | 6.48e-05 | 12 | 21 | 2 | GO:0032383 | |
| GeneOntologyBiologicalProcess | regulation of intracellular lipid transport | 7.65e-05 | 13 | 21 | 2 | GO:0032377 | |
| GeneOntologyBiologicalProcess | regulation of receptor catabolic process | 8.92e-05 | 14 | 21 | 2 | GO:2000644 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 1.11e-04 | 252 | 21 | 4 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 1.11e-04 | 252 | 21 | 4 | GO:0006486 | |
| GeneOntologyBiologicalProcess | glycosylation | 1.44e-04 | 270 | 21 | 4 | GO:0070085 | |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 1.46e-04 | 102 | 21 | 3 | GO:1903432 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor recycling | 1.50e-04 | 18 | 21 | 2 | GO:0001921 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 1.78e-04 | 109 | 21 | 3 | GO:0038202 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane organization | 1.86e-04 | 20 | 21 | 2 | GO:1903729 | |
| GeneOntologyBiologicalProcess | regulation of receptor binding | 2.69e-04 | 24 | 21 | 2 | GO:1900120 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle clearance | 2.69e-04 | 24 | 21 | 2 | GO:0010988 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 3.94e-04 | 29 | 21 | 2 | GO:0042730 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 4.18e-04 | 357 | 21 | 4 | GO:0009101 | |
| GeneOntologyBiologicalProcess | receptor catabolic process | 4.51e-04 | 31 | 21 | 2 | GO:0032801 | |
| GeneOntologyBiologicalProcess | regulation of receptor recycling | 4.51e-04 | 31 | 21 | 2 | GO:0001919 | |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 5.30e-04 | 158 | 21 | 3 | GO:0032006 | |
| GeneOntologyBiologicalProcess | plasma membrane repair | 5.43e-04 | 34 | 21 | 2 | GO:0001778 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 6.09e-04 | 36 | 21 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | intracellular cholesterol transport | 6.09e-04 | 36 | 21 | 2 | GO:0032367 | |
| GeneOntologyBiologicalProcess | regulation of lipoprotein particle clearance | 7.15e-04 | 39 | 21 | 2 | GO:0010984 | |
| GeneOntologyBiologicalProcess | intracellular sterol transport | 7.15e-04 | 39 | 21 | 2 | GO:0032366 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 7.52e-04 | 40 | 21 | 2 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 7.52e-04 | 40 | 21 | 2 | GO:0032376 | |
| GeneOntologyBiologicalProcess | TOR signaling | 7.87e-04 | 181 | 21 | 3 | GO:0031929 | |
| GeneOntologyBiologicalProcess | export from cell | 7.90e-04 | 1153 | 21 | 6 | GO:0140352 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle clearance | 7.90e-04 | 41 | 21 | 2 | GO:0034383 | |
| GeneOntologyBiologicalProcess | cellular response to starvation | 8.38e-04 | 185 | 21 | 3 | GO:0009267 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 8.41e-04 | 430 | 21 | 4 | GO:0009100 | |
| GeneOntologyBiologicalProcess | cellular response to glucose starvation | 1.08e-03 | 48 | 21 | 2 | GO:0042149 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.27e-03 | 52 | 21 | 2 | GO:0042789 | |
| GeneOntologyBiologicalProcess | intracellular lipid transport | 1.32e-03 | 53 | 21 | 2 | GO:0032365 | |
| GeneOntologyBiologicalProcess | receptor recycling | 1.42e-03 | 55 | 21 | 2 | GO:0001881 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.52e-03 | 57 | 21 | 2 | GO:0009299 | |
| GeneOntologyBiologicalProcess | response to starvation | 1.55e-03 | 229 | 21 | 3 | GO:0042594 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle clearance | 1.86e-03 | 63 | 21 | 2 | GO:0034381 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis | 2.10e-03 | 67 | 21 | 2 | GO:0048260 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.22e-03 | 69 | 21 | 2 | GO:0030195 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 2.28e-03 | 262 | 21 | 3 | GO:0031669 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.29e-03 | 70 | 21 | 2 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.42e-03 | 72 | 21 | 2 | GO:0050819 | |
| GeneOntologyBiologicalProcess | lung development | 2.45e-03 | 269 | 21 | 3 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.56e-03 | 273 | 21 | 3 | GO:0030323 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.69e-03 | 76 | 21 | 2 | GO:0030199 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 3.12e-03 | 82 | 21 | 2 | GO:0043112 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 3.20e-03 | 83 | 21 | 2 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 3.20e-03 | 83 | 21 | 2 | GO:0032371 | |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 3.35e-03 | 85 | 21 | 2 | GO:0032092 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 3.35e-03 | 85 | 21 | 2 | GO:0048146 | |
| GeneOntologyBiologicalProcess | respiratory system development | 3.50e-03 | 305 | 21 | 3 | GO:0060541 | |
| GeneOntologyBiologicalProcess | response to activity | 3.75e-03 | 90 | 21 | 2 | GO:0014823 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 3.83e-03 | 91 | 21 | 2 | GO:0140115 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.83e-03 | 91 | 21 | 2 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 3.99e-03 | 93 | 21 | 2 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 4.25e-03 | 96 | 21 | 2 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.42e-03 | 98 | 21 | 2 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 4.69e-03 | 101 | 21 | 2 | GO:0002028 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 4.78e-03 | 102 | 21 | 2 | GO:0032370 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 4.87e-03 | 103 | 21 | 2 | GO:0097006 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 5.06e-03 | 105 | 21 | 2 | GO:0006493 | |
| GeneOntologyBiologicalProcess | positive regulation of exocytosis | 5.25e-03 | 107 | 21 | 2 | GO:0045921 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 5.93e-03 | 736 | 21 | 4 | GO:1901137 | |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 2.88e-06 | 3 | 21 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 2.88e-06 | 3 | 21 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 2.01e-05 | 7 | 21 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | pinosome | 5.26e-05 | 11 | 21 | 2 | GO:0044352 | |
| GeneOntologyCellularComponent | macropinosome | 5.26e-05 | 11 | 21 | 2 | GO:0044354 | |
| GeneOntologyCellularComponent | Schmidt-Lanterman incisure | 1.30e-04 | 17 | 21 | 2 | GO:0043220 | |
| GeneOntologyCellularComponent | pigment granule | 1.91e-04 | 113 | 21 | 3 | GO:0048770 | |
| GeneOntologyCellularComponent | melanosome | 1.91e-04 | 113 | 21 | 3 | GO:0042470 | |
| GeneOntologyCellularComponent | compact myelin | 2.00e-04 | 21 | 21 | 2 | GO:0043218 | |
| GeneOntologyCellularComponent | nuclear matrix | 3.58e-04 | 140 | 21 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | late endosome | 3.61e-04 | 348 | 21 | 4 | GO:0005770 | |
| GeneOntologyCellularComponent | nuclear periphery | 6.42e-04 | 171 | 21 | 3 | GO:0034399 | |
| GeneOntologyCellularComponent | sarcolemma | 8.71e-04 | 190 | 21 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | lysosomal membrane | 1.05e-03 | 462 | 21 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.05e-03 | 462 | 21 | 4 | GO:0098852 | |
| GeneOntologyCellularComponent | myelin sheath | 1.28e-03 | 217 | 21 | 3 | GO:0043209 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.34e-03 | 1293 | 21 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.37e-03 | 1299 | 21 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.47e-03 | 507 | 21 | 4 | GO:0005774 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.53e-03 | 1327 | 21 | 6 | GO:0042175 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.97e-03 | 934 | 21 | 5 | GO:0048471 | |
| GeneOntologyCellularComponent | intercalated disc | 2.10e-03 | 68 | 21 | 2 | GO:0014704 | |
| GeneOntologyCellularComponent | cornified envelope | 2.17e-03 | 69 | 21 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | anchoring junction | 2.39e-03 | 976 | 21 | 5 | GO:0070161 | |
| GeneOntologyCellularComponent | endosome membrane | 2.76e-03 | 602 | 21 | 4 | GO:0010008 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.85e-03 | 320 | 21 | 3 | GO:0016323 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.97e-03 | 94 | 21 | 2 | GO:0044291 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.11e-03 | 354 | 21 | 3 | GO:0009925 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.12e-03 | 107 | 21 | 2 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.12e-03 | 107 | 21 | 2 | GO:0001725 | |
| GeneOntologyCellularComponent | lipid droplet | 5.98e-03 | 116 | 21 | 2 | GO:0005811 | |
| GeneOntologyCellularComponent | actomyosin | 6.08e-03 | 117 | 21 | 2 | GO:0042641 | |
| GeneOntologyCellularComponent | basal part of cell | 6.13e-03 | 378 | 21 | 3 | GO:0045178 | |
| GeneOntologyCellularComponent | actin filament bundle | 6.19e-03 | 118 | 21 | 2 | GO:0032432 | |
| GeneOntologyCellularComponent | basement membrane | 6.60e-03 | 122 | 21 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | lysosome | 7.94e-03 | 811 | 21 | 4 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 7.94e-03 | 811 | 21 | 4 | GO:0000323 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 8.31e-03 | 1307 | 21 | 5 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 8.80e-03 | 1325 | 21 | 5 | GO:0012506 | |
| GeneOntologyCellularComponent | vacuole | 1.19e-02 | 913 | 21 | 4 | GO:0005773 | |
| Domain | 14_3_3 | 3.67e-08 | 7 | 20 | 3 | SM00101 | |
| Domain | 14-3-3_CS | 3.67e-08 | 7 | 20 | 3 | IPR023409 | |
| Domain | 1433_1 | 3.67e-08 | 7 | 20 | 3 | PS00796 | |
| Domain | 1433_2 | 3.67e-08 | 7 | 20 | 3 | PS00797 | |
| Domain | 14-3-3 | 3.67e-08 | 7 | 20 | 3 | PF00244 | |
| Domain | 14-3-3_domain | 3.67e-08 | 7 | 20 | 3 | IPR023410 | |
| Domain | 14-3-3 | 5.86e-08 | 8 | 20 | 3 | IPR000308 | |
| Domain | TLC | 1.30e-04 | 16 | 20 | 2 | PS50922 | |
| Domain | TLC-dom | 1.30e-04 | 16 | 20 | 2 | IPR006634 | |
| Domain | TLC | 1.30e-04 | 16 | 20 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 1.30e-04 | 16 | 20 | 2 | PF03798 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 3.82e-07 | 12 | 18 | 3 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 3.82e-07 | 12 | 18 | 3 | MM15443 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.82e-07 | 12 | 18 | 3 | MM14482 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 4.96e-07 | 13 | 18 | 3 | M27708 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 4.96e-07 | 13 | 18 | 3 | M47589 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 7.88e-07 | 15 | 18 | 3 | M26902 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 9.69e-07 | 16 | 18 | 3 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.41e-06 | 18 | 18 | 3 | MM14510 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 2.29e-06 | 21 | 18 | 3 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 2.29e-06 | 21 | 18 | 3 | M199 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 3.05e-06 | 23 | 18 | 3 | MM15216 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 4.46e-06 | 26 | 18 | 3 | M247 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 6.95e-06 | 30 | 18 | 3 | M17814 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.12e-05 | 35 | 18 | 3 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 1.22e-05 | 36 | 18 | 3 | M271 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.68e-05 | 40 | 18 | 3 | MM14473 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.56e-05 | 46 | 18 | 3 | M239 | |
| Pathway | PID_LKB1_PATHWAY | 2.74e-05 | 47 | 18 | 3 | M87 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.10e-05 | 147 | 18 | 4 | MM15854 | |
| Pathway | PID_FOXO_PATHWAY | 3.10e-05 | 49 | 18 | 3 | M136 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.44e-05 | 151 | 18 | 4 | M39329 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 3.50e-05 | 51 | 18 | 3 | M7955 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.72e-05 | 154 | 18 | 4 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.91e-05 | 156 | 18 | 4 | M39475 | |
| Pathway | PID_NFAT_3PATHWAY | 3.93e-05 | 53 | 18 | 3 | M113 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 4.40e-05 | 55 | 18 | 3 | M7455 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 7.96e-05 | 67 | 18 | 3 | M295 | |
| Pathway | PID_MTOR_4PATHWAY | 8.69e-05 | 69 | 18 | 3 | M121 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 9.87e-05 | 72 | 18 | 3 | MM15381 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 9.87e-05 | 72 | 18 | 3 | M26954 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.01e-04 | 12 | 18 | 2 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.01e-04 | 12 | 18 | 2 | M27939 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.03e-04 | 73 | 18 | 3 | MM15223 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.35e-04 | 80 | 18 | 3 | M223 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.56e-04 | 84 | 18 | 3 | M27495 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 1.60e-04 | 15 | 18 | 2 | MM15450 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.11e-04 | 93 | 18 | 3 | M27487 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.18e-04 | 94 | 18 | 3 | M1080 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 2.46e-04 | 98 | 18 | 3 | M46424 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.70e-04 | 257 | 18 | 4 | MM14755 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 3.02e-04 | 105 | 18 | 3 | M164 | |
| Pathway | REACTOME_APOPTOSIS | 3.28e-04 | 108 | 18 | 3 | MM14471 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.30e-04 | 271 | 18 | 4 | MM15388 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 3.50e-04 | 22 | 18 | 2 | MM15656 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.75e-04 | 113 | 18 | 3 | M16817 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 4.33e-04 | 291 | 18 | 4 | M16647 | |
| Pathway | WP_CELL_CYCLE | 4.47e-04 | 120 | 18 | 3 | M39650 | |
| Pathway | PID_IL3_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M182 | |
| Pathway | KEGG_CELL_CYCLE | 5.04e-04 | 125 | 18 | 3 | M7963 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 5.16e-04 | 126 | 18 | 3 | M16763 | |
| Pathway | PID_PDGFRB_PATHWAY | 5.52e-04 | 129 | 18 | 3 | M186 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 6.42e-04 | 323 | 18 | 4 | M27080 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 7.31e-04 | 142 | 18 | 3 | MM15178 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 7.46e-04 | 143 | 18 | 3 | MM15383 | |
| Pathway | REACTOME_SARS_COV_1_INFECTION | 7.46e-04 | 143 | 18 | 3 | M39006 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 7.47e-04 | 32 | 18 | 2 | MM15850 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 9.25e-04 | 630 | 18 | 5 | M11480 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.01e-03 | 159 | 18 | 3 | M39373 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.17e-03 | 167 | 18 | 3 | M19381 | |
| Pathway | REACTOME_APOPTOSIS | 1.43e-03 | 179 | 18 | 3 | M15303 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 1.74e-03 | 725 | 18 | 5 | M27507 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 2.08e-03 | 204 | 18 | 3 | M45011 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 2.29e-03 | 211 | 18 | 3 | M27436 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.15e-03 | 66 | 18 | 2 | MM15925 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 3.15e-03 | 66 | 18 | 2 | M27938 | |
| Pathway | WP_PROLACTIN_SIGNALING | 4.15e-03 | 76 | 18 | 2 | M39601 | |
| Pathway | REACTOME_HEMOSTASIS | 5.18e-03 | 571 | 18 | 4 | MM14472 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 6.09e-03 | 299 | 18 | 3 | M41727 | |
| Pathway | REACTOME_CELL_CYCLE | 6.28e-03 | 603 | 18 | 4 | MM14635 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 6.37e-03 | 304 | 18 | 3 | MM14960 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 6.55e-03 | 307 | 18 | 3 | M894 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 8.13e-03 | 649 | 18 | 4 | MM15690 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 1.01e-02 | 360 | 18 | 3 | M27267 | |
| Pathway | REACTOME_CELL_CYCLE | 1.03e-02 | 694 | 18 | 4 | M543 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.16e-02 | 720 | 18 | 4 | M41838 | |
| Pubmed | Analysis of phosphorylation-dependent protein-protein interactions of histone h3. | 5.84e-10 | 21 | 21 | 4 | 25330109 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.93e-09 | 89 | 21 | 5 | 27034005 | |
| Pubmed | 3.79e-09 | 6 | 21 | 3 | 16672277 | ||
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 3.79e-09 | 6 | 21 | 3 | 19860830 | |
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 27030597 | ||
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 10620507 | ||
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 21390248 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 6.63e-09 | 7 | 21 | 3 | 12383250 | |
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 6.63e-09 | 7 | 21 | 3 | 36096339 | |
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 6.63e-09 | 7 | 21 | 3 | 20388496 | |
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 16868027 | ||
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 31906564 | ||
| Pubmed | 1.06e-08 | 8 | 21 | 3 | 16045749 | ||
| Pubmed | 1.06e-08 | 8 | 21 | 3 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 1.06e-08 | 8 | 21 | 3 | 9524113 | |
| Pubmed | Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. | 1.06e-08 | 8 | 21 | 3 | 23075850 | |
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 1.06e-08 | 8 | 21 | 3 | 23622247 | |
| Pubmed | 1.06e-08 | 8 | 21 | 3 | 18332103 | ||
| Pubmed | 1.06e-08 | 8 | 21 | 3 | 8702721 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.29e-08 | 281 | 21 | 6 | 28706196 | |
| Pubmed | 1.59e-08 | 9 | 21 | 3 | 18458160 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 1.59e-08 | 9 | 21 | 3 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 1.59e-08 | 9 | 21 | 3 | 12438239 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 1.59e-08 | 9 | 21 | 3 | 12176984 | |
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 1.59e-08 | 9 | 21 | 3 | 34294877 | |
| Pubmed | 1.59e-08 | 9 | 21 | 3 | 16581770 | ||
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 1.59e-08 | 9 | 21 | 3 | 16511560 | |
| Pubmed | 1.59e-08 | 9 | 21 | 3 | 12446771 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 2.27e-08 | 10 | 21 | 3 | 15791647 | |
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 2.27e-08 | 10 | 21 | 3 | 14505491 | |
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 2.27e-08 | 10 | 21 | 3 | 25154416 | |
| Pubmed | 2.27e-08 | 10 | 21 | 3 | 20478393 | ||
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 2.27e-08 | 10 | 21 | 3 | 11697890 | |
| Pubmed | 2.27e-08 | 10 | 21 | 3 | 12433946 | ||
| Pubmed | 3.12e-08 | 11 | 21 | 3 | 15696159 | ||
| Pubmed | 4.07e-08 | 163 | 21 | 5 | 16512683 | ||
| Pubmed | 4.16e-08 | 12 | 21 | 3 | 39406751 | ||
| Pubmed | 4.16e-08 | 12 | 21 | 3 | 20642453 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 4.16e-08 | 12 | 21 | 3 | 19172738 | |
| Pubmed | 4.16e-08 | 12 | 21 | 3 | 18779327 | ||
| Pubmed | 5.40e-08 | 13 | 21 | 3 | 34654719 | ||
| Pubmed | 5.40e-08 | 13 | 21 | 3 | 22222486 | ||
| Pubmed | 5.40e-08 | 13 | 21 | 3 | 19014373 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 6.88e-08 | 14 | 21 | 3 | 36806887 | |
| Pubmed | 6.88e-08 | 14 | 21 | 3 | 16093354 | ||
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 6.88e-08 | 14 | 21 | 3 | 33761321 | |
| Pubmed | 6.88e-08 | 14 | 21 | 3 | 15265780 | ||
| Pubmed | 8.59e-08 | 15 | 21 | 3 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 8.59e-08 | 15 | 21 | 3 | 16041367 | |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 1.06e-07 | 16 | 21 | 3 | 23071090 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 1.28e-07 | 17 | 21 | 3 | 37045861 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 1.54e-07 | 18 | 21 | 3 | 30240640 | |
| Pubmed | 1.83e-07 | 19 | 21 | 3 | 35343654 | ||
| Pubmed | 1.83e-07 | 19 | 21 | 3 | 18160415 | ||
| Pubmed | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. | 1.83e-07 | 19 | 21 | 3 | 15142377 | |
| Pubmed | 2.29e-07 | 457 | 21 | 6 | 22190034 | ||
| Pubmed | 2.51e-07 | 21 | 21 | 3 | 23428871 | ||
| Pubmed | Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | 3.47e-07 | 2 | 21 | 2 | 38092984 | |
| Pubmed | The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. | 3.47e-07 | 2 | 21 | 2 | 12176032 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21572519 | ||
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 3.47e-07 | 2 | 21 | 2 | 19841537 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21788340 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38290972 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27371724 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38253182 | ||
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 3.47e-07 | 2 | 21 | 2 | 21486955 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 3013423 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35064931 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 3.47e-07 | 2 | 21 | 2 | 28130864 | |
| Pubmed | Agents that bind annexin A2 suppress ocular neovascularization. | 3.47e-07 | 2 | 21 | 2 | 20607799 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27389701 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 31253864 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 36739096 | ||
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 3.47e-07 | 2 | 21 | 2 | 21737841 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19536308 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 23977325 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17549680 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22517898 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 31817350 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 37832154 | ||
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 3.47e-07 | 2 | 21 | 2 | 23148505 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17360942 | ||
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 3.47e-07 | 2 | 21 | 2 | 22185818 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 39384746 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 3.47e-07 | 2 | 21 | 2 | 19587120 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19580511 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 30462534 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19628708 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 30902828 | ||
| Pubmed | Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. | 3.47e-07 | 2 | 21 | 2 | 15654879 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20826156 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19022301 | ||
| Pubmed | Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. | 3.47e-07 | 2 | 21 | 2 | 24742684 | |
| Pubmed | Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. | 3.47e-07 | 2 | 21 | 2 | 20847146 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 32687500 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 3.47e-07 | 2 | 21 | 2 | 27468426 | |
| Pubmed | Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. | 3.47e-07 | 2 | 21 | 2 | 22453828 | |
| Pubmed | 4.33e-07 | 25 | 21 | 3 | 21145499 | ||
| Pubmed | 4.89e-07 | 26 | 21 | 3 | 11531413 | ||
| Pubmed | 6.15e-07 | 28 | 21 | 3 | 20012529 | ||
| Interaction | MACIR interactions | 2.69e-08 | 31 | 21 | 4 | int:MACIR | |
| Interaction | FAM86C1P interactions | 4.47e-08 | 35 | 21 | 4 | int:FAM86C1P | |
| Interaction | KCNK15 interactions | 5.44e-08 | 8 | 21 | 3 | int:KCNK15 | |
| Interaction | KCNK9 interactions | 8.16e-08 | 9 | 21 | 3 | int:KCNK9 | |
| Interaction | OTOG interactions | 1.16e-07 | 10 | 21 | 3 | int:OTOG | |
| Interaction | CDCA7 interactions | 1.60e-07 | 11 | 21 | 3 | int:CDCA7 | |
| Interaction | PPP1R3E interactions | 2.13e-07 | 12 | 21 | 3 | int:PPP1R3E | |
| Interaction | TFEB interactions | 2.28e-07 | 52 | 21 | 4 | int:TFEB | |
| Interaction | KCNK3 interactions | 2.77e-07 | 13 | 21 | 3 | int:KCNK3 | |
| Interaction | TTLL7 interactions | 4.40e-07 | 15 | 21 | 3 | int:TTLL7 | |
| Interaction | SAMSN1 interactions | 5.41e-07 | 16 | 21 | 3 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 5.41e-07 | 16 | 21 | 3 | int:TESPA1 | |
| Interaction | ZNF395 interactions | 6.57e-07 | 17 | 21 | 3 | int:ZNF395 | |
| Interaction | CKAP5 interactions | 7.04e-07 | 322 | 21 | 6 | int:CKAP5 | |
| Interaction | FAM53B interactions | 7.88e-07 | 18 | 21 | 3 | int:FAM53B | |
| Interaction | FAM163A interactions | 9.35e-07 | 19 | 21 | 3 | int:FAM163A | |
| Interaction | PARP8 interactions | 1.10e-06 | 20 | 21 | 3 | int:PARP8 | |
| Interaction | MLXIP interactions | 1.10e-06 | 20 | 21 | 3 | int:MLXIP | |
| Interaction | SIK3 interactions | 1.24e-06 | 79 | 21 | 4 | int:SIK3 | |
| Interaction | PITPNC1 interactions | 1.28e-06 | 21 | 21 | 3 | int:PITPNC1 | |
| Interaction | STOX2 interactions | 1.28e-06 | 21 | 21 | 3 | int:STOX2 | |
| Interaction | DENND1B interactions | 1.28e-06 | 21 | 21 | 3 | int:DENND1B | |
| Interaction | SPATA13 interactions | 1.28e-06 | 21 | 21 | 3 | int:SPATA13 | |
| Interaction | SPIRE2 interactions | 1.28e-06 | 21 | 21 | 3 | int:SPIRE2 | |
| Interaction | PPP1R3D interactions | 1.48e-06 | 22 | 21 | 3 | int:PPP1R3D | |
| Interaction | PPP4R4 interactions | 1.48e-06 | 22 | 21 | 3 | int:PPP4R4 | |
| Interaction | ATAT1 interactions | 1.48e-06 | 22 | 21 | 3 | int:ATAT1 | |
| Interaction | OSBPL6 interactions | 1.59e-06 | 84 | 21 | 4 | int:OSBPL6 | |
| Interaction | CCSER1 interactions | 1.70e-06 | 23 | 21 | 3 | int:CCSER1 | |
| Interaction | GLCCI1 interactions | 1.70e-06 | 23 | 21 | 3 | int:GLCCI1 | |
| Interaction | RABGEF1 interactions | 1.80e-06 | 204 | 21 | 5 | int:RABGEF1 | |
| Interaction | E2F8 interactions | 1.95e-06 | 24 | 21 | 3 | int:E2F8 | |
| Interaction | PACS2 interactions | 1.95e-06 | 24 | 21 | 3 | int:PACS2 | |
| Interaction | TMCC1 interactions | 2.21e-06 | 25 | 21 | 3 | int:TMCC1 | |
| Interaction | LNP1 interactions | 2.21e-06 | 25 | 21 | 3 | int:LNP1 | |
| Interaction | C6orf132 interactions | 2.21e-06 | 25 | 21 | 3 | int:C6orf132 | |
| Interaction | TMEM102 interactions | 2.21e-06 | 25 | 21 | 3 | int:TMEM102 | |
| Interaction | MAST4 interactions | 2.50e-06 | 26 | 21 | 3 | int:MAST4 | |
| Interaction | PLEKHM3 interactions | 2.50e-06 | 26 | 21 | 3 | int:PLEKHM3 | |
| Interaction | FAM83G interactions | 2.50e-06 | 26 | 21 | 3 | int:FAM83G | |
| Interaction | GRIP1 interactions | 2.72e-06 | 96 | 21 | 4 | int:GRIP1 | |
| Interaction | SPRYD3 interactions | 2.81e-06 | 27 | 21 | 3 | int:SPRYD3 | |
| Interaction | SPIRE1 interactions | 2.81e-06 | 27 | 21 | 3 | int:SPIRE1 | |
| Interaction | SEC24A interactions | 2.86e-06 | 224 | 21 | 5 | int:SEC24A | |
| Interaction | CARMIL2 interactions | 3.14e-06 | 28 | 21 | 3 | int:CARMIL2 | |
| Interaction | USP31 interactions | 3.14e-06 | 28 | 21 | 3 | int:USP31 | |
| Interaction | WWC2 interactions | 3.14e-06 | 28 | 21 | 3 | int:WWC2 | |
| Interaction | DENND2B interactions | 3.14e-06 | 28 | 21 | 3 | int:DENND2B | |
| Interaction | PLEKHA3 interactions | 3.14e-06 | 28 | 21 | 3 | int:PLEKHA3 | |
| Interaction | SPATA18 interactions | 3.14e-06 | 28 | 21 | 3 | int:SPATA18 | |
| Interaction | KIAA0930 interactions | 3.14e-06 | 28 | 21 | 3 | int:KIAA0930 | |
| Interaction | SPEG interactions | 3.50e-06 | 29 | 21 | 3 | int:SPEG | |
| Interaction | FAM13A interactions | 3.50e-06 | 29 | 21 | 3 | int:FAM13A | |
| Interaction | ARAP2 interactions | 3.89e-06 | 30 | 21 | 3 | int:ARAP2 | |
| Interaction | NCAM2 interactions | 3.89e-06 | 30 | 21 | 3 | int:NCAM2 | |
| Interaction | HIVEP2 interactions | 3.89e-06 | 30 | 21 | 3 | int:HIVEP2 | |
| Interaction | TICRR interactions | 3.89e-06 | 30 | 21 | 3 | int:TICRR | |
| Interaction | ZFP36L1 interactions | 3.89e-06 | 30 | 21 | 3 | int:ZFP36L1 | |
| Interaction | ERRFI1 interactions | 4.19e-06 | 107 | 21 | 4 | int:ERRFI1 | |
| Interaction | PABIR1 interactions | 4.30e-06 | 31 | 21 | 3 | int:PABIR1 | |
| Interaction | MAP3K9 interactions | 4.30e-06 | 31 | 21 | 3 | int:MAP3K9 | |
| Interaction | ALS2 interactions | 4.30e-06 | 31 | 21 | 3 | int:ALS2 | |
| Interaction | CRTC1 interactions | 4.30e-06 | 31 | 21 | 3 | int:CRTC1 | |
| Interaction | OSBPL3 interactions | 4.68e-06 | 110 | 21 | 4 | int:OSBPL3 | |
| Interaction | AKT1S1 interactions | 4.74e-06 | 32 | 21 | 3 | int:AKT1S1 | |
| Interaction | CEP112 interactions | 4.74e-06 | 32 | 21 | 3 | int:CEP112 | |
| Interaction | SH3BP5L interactions | 5.21e-06 | 33 | 21 | 3 | int:SH3BP5L | |
| Interaction | CEP85L interactions | 5.21e-06 | 33 | 21 | 3 | int:CEP85L | |
| Interaction | ARL14EP interactions | 5.21e-06 | 33 | 21 | 3 | int:ARL14EP | |
| Interaction | KLC1 interactions | 5.38e-06 | 255 | 21 | 5 | int:KLC1 | |
| Interaction | PDE3B interactions | 5.59e-06 | 115 | 21 | 4 | int:PDE3B | |
| Interaction | KCNQ5 interactions | 5.72e-06 | 34 | 21 | 3 | int:KCNQ5 | |
| Interaction | REEP3 interactions | 5.72e-06 | 34 | 21 | 3 | int:REEP3 | |
| Interaction | AKAP13 interactions | 5.78e-06 | 116 | 21 | 4 | int:AKAP13 | |
| Interaction | NDE1 interactions | 5.98e-06 | 117 | 21 | 4 | int:NDE1 | |
| Interaction | SMTNL2 interactions | 6.25e-06 | 35 | 21 | 3 | int:SMTNL2 | |
| Interaction | FOXO4 interactions | 6.25e-06 | 35 | 21 | 3 | int:FOXO4 | |
| Interaction | SORBS1 interactions | 7.30e-06 | 123 | 21 | 4 | int:SORBS1 | |
| Interaction | PANK2 interactions | 7.41e-06 | 37 | 21 | 3 | int:PANK2 | |
| Interaction | JUP interactions | 7.52e-06 | 485 | 21 | 6 | int:JUP | |
| Interaction | TNK1 interactions | 8.04e-06 | 38 | 21 | 3 | int:TNK1 | |
| Interaction | PLEKHG5 interactions | 8.04e-06 | 38 | 21 | 3 | int:PLEKHG5 | |
| Interaction | RUSC2 interactions | 8.04e-06 | 38 | 21 | 3 | int:RUSC2 | |
| Interaction | STARD9 interactions | 8.04e-06 | 38 | 21 | 3 | int:STARD9 | |
| Interaction | PFKFB4 interactions | 8.04e-06 | 38 | 21 | 3 | int:PFKFB4 | |
| Interaction | TMCC3 interactions | 8.70e-06 | 39 | 21 | 3 | int:TMCC3 | |
| Interaction | PRR5 interactions | 8.70e-06 | 39 | 21 | 3 | int:PRR5 | |
| Interaction | BAIAP2L1 interactions | 8.81e-06 | 129 | 21 | 4 | int:BAIAP2L1 | |
| Interaction | CDK18 interactions | 9.37e-06 | 131 | 21 | 4 | int:CDK18 | |
| Interaction | ATXN2L interactions | 9.39e-06 | 286 | 21 | 5 | int:ATXN2L | |
| Interaction | HECTD4 interactions | 9.40e-06 | 40 | 21 | 3 | int:HECTD4 | |
| Interaction | PABIR2 interactions | 9.40e-06 | 40 | 21 | 3 | int:PABIR2 | |
| Interaction | FGD6 interactions | 9.40e-06 | 40 | 21 | 3 | int:FGD6 | |
| Interaction | MTBP interactions | 9.40e-06 | 40 | 21 | 3 | int:MTBP | |
| Interaction | FAM117B interactions | 9.40e-06 | 40 | 21 | 3 | int:FAM117B | |
| Interaction | KANK1 interactions | 9.40e-06 | 40 | 21 | 3 | int:KANK1 | |
| Interaction | NKD2 interactions | 9.40e-06 | 40 | 21 | 3 | int:NKD2 | |
| Interaction | SIPA1 interactions | 1.01e-05 | 41 | 21 | 3 | int:SIPA1 | |
| Interaction | INPP5F interactions | 1.01e-05 | 41 | 21 | 3 | int:INPP5F | |
| Interaction | JCAD interactions | 1.09e-05 | 42 | 21 | 3 | int:JCAD | |
| Cytoband | 22q12.3 | 1.04e-04 | 33 | 21 | 2 | 22q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 5.14e-03 | 235 | 21 | 2 | chr22q12 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.29e-08 | 7 | 14 | 3 | 1053 | |
| GeneFamily | Solute carriers | 3.64e-02 | 395 | 14 | 2 | 752 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.14e-06 | 26 | 21 | 3 | M1380 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN | 1.36e-06 | 250 | 21 | 5 | M13333 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | 6.21e-06 | 341 | 21 | 5 | M12636 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.15e-05 | 179 | 21 | 4 | M39308 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN | 1.64e-05 | 196 | 21 | 4 | M4433 | |
| Coexpression | ZHANG_UTERUS_C0_MATURATIONAL_UP | 1.71e-05 | 8 | 21 | 2 | MM16603 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_UP | 1.72e-05 | 421 | 21 | 5 | M18149 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN | 1.78e-05 | 200 | 21 | 4 | M7644 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP | 1.78e-05 | 200 | 21 | 4 | M8539 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN | 1.78e-05 | 200 | 21 | 4 | M9274 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 1.78e-05 | 200 | 21 | 4 | M7878 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 4.35e-05 | 86 | 21 | 3 | MM1209 | |
| Coexpression | SEIDEN_ONCOGENESIS_BY_MET | 4.82e-05 | 89 | 21 | 3 | M3231 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_T_CELL_AGEING | 5.58e-05 | 268 | 21 | 4 | MM3835 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 1.39e-04 | 127 | 21 | 3 | MM1289 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_UP | 1.45e-04 | 343 | 21 | 4 | MM1059 | |
| Coexpression | CRX_DN.V1_DN | 1.55e-04 | 132 | 21 | 3 | M2792 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN | 1.81e-04 | 25 | 21 | 2 | M7678 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 1.96e-04 | 26 | 21 | 2 | M47981 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 3.00e-04 | 165 | 21 | 3 | M337 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_DN | 3.00e-04 | 165 | 21 | 3 | M8246 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | 3.38e-04 | 792 | 21 | 5 | M12113 | |
| Coexpression | GUTIERREZ_MULTIPLE_MYELOMA_UP | 3.79e-04 | 36 | 21 | 2 | M19443 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.80e-04 | 179 | 21 | 3 | MM660 | |
| Coexpression | HU_FETAL_RETINA_RGC | 3.84e-04 | 443 | 21 | 4 | M39269 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 4.22e-04 | 38 | 21 | 2 | M47982 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 4.53e-04 | 190 | 21 | 3 | MM3832 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN | 4.96e-04 | 196 | 21 | 3 | M3183 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 5.03e-04 | 197 | 21 | 3 | M5347 | |
| Coexpression | GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN | 5.03e-04 | 197 | 21 | 3 | M4436 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN | 5.03e-04 | 197 | 21 | 3 | M6901 | |
| Coexpression | GSE3982_BASOPHIL_VS_NKCELL_UP | 5.11e-04 | 198 | 21 | 3 | M5561 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_UP | 5.11e-04 | 198 | 21 | 3 | M10031 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 5.11e-04 | 198 | 21 | 3 | M5344 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_DN | 5.18e-04 | 199 | 21 | 3 | M4467 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M9476 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN | 5.26e-04 | 200 | 21 | 3 | M7767 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN | 5.26e-04 | 200 | 21 | 3 | M5130 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN | 5.26e-04 | 200 | 21 | 3 | M3790 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN | 5.26e-04 | 200 | 21 | 3 | M7196 | |
| Coexpression | GSE29618_PDC_VS_MDC_DN | 5.26e-04 | 200 | 21 | 3 | M4952 | |
| Coexpression | GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP | 5.26e-04 | 200 | 21 | 3 | M7611 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M7653 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP | 5.26e-04 | 200 | 21 | 3 | M9235 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN | 5.26e-04 | 200 | 21 | 3 | M9263 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN | 5.26e-04 | 200 | 21 | 3 | M3963 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN | 5.26e-04 | 200 | 21 | 3 | M4486 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_DN | 5.26e-04 | 200 | 21 | 3 | M4899 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M7868 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_LUNG_DN | 5.26e-04 | 200 | 21 | 3 | M4369 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M3039 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP | 5.26e-04 | 200 | 21 | 3 | M7433 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP | 5.26e-04 | 200 | 21 | 3 | M3415 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP | 5.26e-04 | 200 | 21 | 3 | M6953 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 5.73e-04 | 206 | 21 | 3 | M39254 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 5.90e-04 | 208 | 21 | 3 | M1376 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 6.15e-04 | 211 | 21 | 3 | MM17081 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 6.20e-04 | 1399 | 21 | 6 | M535 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 7.12e-04 | 222 | 21 | 3 | MM1132 | |
| Coexpression | FRASOR_TAMOXIFEN_RESPONSE_UP | 7.61e-04 | 51 | 21 | 2 | M17651 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 7.79e-04 | 229 | 21 | 3 | MM16607 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 9.50e-04 | 57 | 21 | 2 | MM527 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 9.74e-04 | 568 | 21 | 4 | M4023 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_DN | 1.05e-03 | 60 | 21 | 2 | M7735 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_DN | 1.09e-03 | 61 | 21 | 2 | MM790 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN | 1.12e-03 | 590 | 21 | 4 | M16066 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | 1.13e-03 | 1033 | 21 | 5 | M4196 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 1.20e-03 | 64 | 21 | 2 | MM671 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_DN | 1.21e-03 | 267 | 21 | 3 | M6663 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 1.31e-03 | 67 | 21 | 2 | M1686 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 1.47e-03 | 71 | 21 | 2 | MM1210 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 196 | 21 | 4 | 799f54131fb1034f82ef4872cfb2c64359541086 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.14e-06 | 200 | 21 | 4 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.92e-05 | 163 | 21 | 3 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 165 | 21 | 3 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.43e-05 | 176 | 21 | 3 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 176 | 21 | 3 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 7.68e-05 | 178 | 21 | 3 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 179 | 21 | 3 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 182 | 21 | 3 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 8.48e-05 | 184 | 21 | 3 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 189 | 21 | 3 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.32e-05 | 190 | 21 | 3 | 4b25d49f033bbd326b47cf5602af3f0262cfc367 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 9.32e-05 | 190 | 21 | 3 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.62e-05 | 192 | 21 | 3 | 8e606eae3e5b07a856d3c2a74186d486da96309c | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 194 | 21 | 3 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 194 | 21 | 3 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 196 | 21 | 3 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 196 | 21 | 3 | 14d68cd628f238395f0e8200e753a4f5daf8902c | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 21 | 3 | 1a30747a2188a890f58d831030328986b3a4356d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-04 | 198 | 21 | 3 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-04 | 198 | 21 | 3 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.05e-04 | 198 | 21 | 3 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell-(010)_cDC|(01)_Dendritic_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.05e-04 | 198 | 21 | 3 | 4abc274edac40f8836255fac2371ffd98a32cccd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.07e-04 | 199 | 21 | 3 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.07e-04 | 199 | 21 | 3 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | tumor_Lung-Myeloid_cells|tumor_Lung / Location, Cell class and cell subclass | 1.07e-04 | 199 | 21 | 3 | a15f7d85efa47245ec6bb398379da1eec9572b75 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 199 | 21 | 3 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.07e-04 | 199 | 21 | 3 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.08e-04 | 200 | 21 | 3 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.08e-04 | 200 | 21 | 3 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.08e-04 | 200 | 21 | 3 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.50e-04 | 67 | 21 | 2 | 8502da9042f40e0a44354776bb507e18ef0cda43 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.50e-04 | 67 | 21 | 2 | e6d051404f095ab9ca95fa6e5ecf0905573a5a63 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.50e-04 | 67 | 21 | 2 | 3a3a3e76f67c1d33bd7b1d0d94c522ad1e1192f8 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.79e-04 | 99 | 21 | 2 | ee38447d5ec394da0e5c406161d18767f35f4b33 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 117 | 21 | 2 | 409b3ab16786bced8c9bc9c0e89b0078402f365a | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 117 | 21 | 2 | 454efceabe739cdf293f81c8a938811f12321a47 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 117 | 21 | 2 | e33ec9044541d2ef53f6633891238559b01b7957 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 117 | 21 | 2 | 91936a3ffbfa29024ced9d01df962b4ccfaf8966 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-03 | 136 | 21 | 2 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-03 | 136 | 21 | 2 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-03 | 136 | 21 | 2 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-03 | 136 | 21 | 2 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-03 | 136 | 21 | 2 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 2.00e-03 | 142 | 21 | 2 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 143 | 21 | 2 | 6e47dfc314909413e7642e3e5ac10c25857708c2 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-03 | 145 | 21 | 2 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 154 | 21 | 2 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.34e-03 | 154 | 21 | 2 | 8a643d91896af9b630a715fb284c1523d01ad1a3 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.34e-03 | 154 | 21 | 2 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 154 | 21 | 2 | 66c93733116e31b65dfb4b0b00de5c39d19cdb84 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-03 | 156 | 21 | 2 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-03 | 157 | 21 | 2 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.59e-03 | 162 | 21 | 2 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.62e-03 | 163 | 21 | 2 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.62e-03 | 163 | 21 | 2 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-03 | 163 | 21 | 2 | edca1d1a345109dbdeb7ee5464faefab1993fdb2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-03 | 165 | 21 | 2 | 2d01ae5d05fe55f6bebd53a5801c4c1f1544515c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 165 | 21 | 2 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | Club-club-16|World / Class top | 2.68e-03 | 165 | 21 | 2 | 684f3c4872bd630d3f744f15d57dccfd34e96160 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-03 | 166 | 21 | 2 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-03 | 166 | 21 | 2 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-03 | 167 | 21 | 2 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-03 | 167 | 21 | 2 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.75e-03 | 167 | 21 | 2 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-03 | 167 | 21 | 2 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 169 | 21 | 2 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 169 | 21 | 2 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.84e-03 | 170 | 21 | 2 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-03 | 170 | 21 | 2 | 52fdf93c2803fecb2a640ef4e0b257786f3d4cb1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-03 | 170 | 21 | 2 | 263e98aa1c49493cc262b2608c6582930841cb10 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.84e-03 | 170 | 21 | 2 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-03 | 170 | 21 | 2 | b535baeb4dbd644051cf992babb61add9eaae4e3 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.84e-03 | 170 | 21 | 2 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-03 | 170 | 21 | 2 | 2477c9f29dbe27f172df699003971e828d6ab8c9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-03 | 171 | 21 | 2 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-03 | 171 | 21 | 2 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-03 | 171 | 21 | 2 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-03 | 171 | 21 | 2 | ff4ab7753320874600e5694f2681e672c144c294 | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-03 | 172 | 21 | 2 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | droplet-Limb_Muscle-nan-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | 770e4c5467ef2eaddf883723fb0aa1226973b000 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 2.91e-03 | 172 | 21 | 2 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | 66823536288c7009ce01b5177794a3e874e94570 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-03 | 172 | 21 | 2 | b440184f2d98d2f2d59566795f44fb79c0647ca4 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 2.91e-03 | 172 | 21 | 2 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-03 | 173 | 21 | 2 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-ectodermal/neuroectodermal-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-03 | 173 | 21 | 2 | 7e4a2f5f92fbed16406bd097c0119278e4053245 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-03 | 173 | 21 | 2 | a8ee017938dd4705361e6fd9a17061ab927027f4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-03 | 173 | 21 | 2 | c1e443c611e6f88ccbba6c019895437aa986414b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-03 | 173 | 21 | 2 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-03 | 173 | 21 | 2 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.94e-03 | 173 | 21 | 2 | 0c9fb18536ddd61b51b7bb4d40841f67b017f360 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-03 | 173 | 21 | 2 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 174 | 21 | 2 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| Drug | bromovanin | 5.13e-06 | 127 | 21 | 4 | ctd:C515564 | |
| Drug | SnMe2Cl2 | 4.43e-05 | 11 | 21 | 2 | CID000012955 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.12e-05 | 80 | 20 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 3.95e-05 | 14 | 20 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 1.63e-04 | 28 | 20 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | bipolar disorder | 5.46e-04 | 577 | 20 | 4 | MONDO_0004985 | |
| Disease | Liver Cirrhosis, Experimental | 1.63e-03 | 774 | 20 | 4 | C0023893 | |
| Disease | Mammary Carcinoma, Animal | 4.13e-03 | 142 | 20 | 2 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 4.13e-03 | 142 | 20 | 2 | C0024667 | |
| Disease | Rheumatoid Arthritis | 6.13e-03 | 174 | 20 | 2 | C0003873 | |
| Disease | hypertension (biomarker_via_orthology) | 1.02e-02 | 227 | 20 | 2 | DOID:10763 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFYLKMKGDYYRYLA | 121 | P61981 | |
| KVKLIYYYLFAFIYG | 231 | Q2TAA5 | |
| VFYLKMKGDYYRYLA | 121 | Q04917 | |
| EFKRKYGKSLYYYIQ | 306 | P07355 | |
| KYLEPVYFYIYTLFG | 151 | Q6ZPD9 | |
| EFKRKYGKSLYYYIQ | 306 | A6NMY6 | |
| FIYGFYFYKIVTDKE | 1251 | O75140 | |
| VYKYIVQKLYGFPYK | 296 | Q9Y6G9 | |
| YYTKGFALLNFVVKY | 641 | O00469 | |
| AFGYKGLKILLYYIA | 66 | O14929 | |
| FYLYVFTYGVRFLKK | 141 | Q6ZMG9 | |
| LFNYYYLKEYLKVVS | 111 | Q96L03 | |
| KYIYFLIKIYPTGLF | 346 | Q7L1T6 | |
| KLKYYIPEVVYSGLY | 286 | Q9NY97 | |
| VFYLKMKGDYYRYLA | 116 | P63104 | |
| CKLAFYLLAFFYYLY | 121 | O95406 | |
| LYAYYLVLKNGVLAY | 126 | Q96MV1 | |
| FYTAKYGYKLCLRLY | 296 | Q13077 | |
| FYFYKEGLYLVKAIN | 171 | Q6P2C0 | |
| LVAAYILYFKPEYKY | 186 | Q9BRI3 | |
| LLFYKYVYKRYRAGK | 256 | P32418 |